This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Overseas Pharmaceuticals, Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Jun Fan in Controlled-Release Tablet Technology
Introduction
Jun Fan is an accomplished inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release medications. His innovative approach has led to advancements that enhance the effectiveness of pain management therapies.
Latest Patents
Jun Fan holds a patent for a controlled-release tablet of ibuprofen and the method for preparing it. This patent describes a unique formulation that includes a drug-containing immediate-release layer and a drug-containing sustained-release layer. The design ensures that the mass of ibuprofen in the sustained-release layer is greater than that in the immediate-release layer, with a specific ratio that optimizes the therapeutic effect. The resulting tablet provides effective analgesic relief for up to 24 hours after administration.
Career Highlights
Throughout his career, Jun Fan has been associated with Overseas Pharmaceuticals, Ltd., where he has focused on pharmaceutical innovations. His work has not only contributed to the company's portfolio but has also advanced the field of drug delivery systems. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.
Collaborations
Jun Fan has collaborated with notable colleagues, including Xiaoguang Wen and Xiaofeng Huang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the development of new pharmaceutical solutions.
Conclusion
Jun Fan's contributions to the field of controlled-release medications exemplify the impact of innovative thinking in pharmaceuticals. His patent for the ibuprofen controlled-release tablet showcases his commitment to improving patient care through effective pain management solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile